Italy: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2025

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Italy

The Italian prophylactic medicaments containing insulin market rose modestly to $X in 2022, surging by 2.1% against the previous year. Over the period under review, consumption continues to indicate a abrupt downturn. Over the period under review, the market hit record highs at $X in 2015; however, from 2016 to 2022, consumption failed to regain momentum.

Production of Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Italy

In value terms, prophylactic medicaments containing insulin production rose modestly to $X in 2022 estimated in export price. Over the period under review, production enjoyed resilient growth. The most prominent rate of growth was recorded in 2013 when the production volume increased by 78% against the previous year. Prophylactic medicaments containing insulin production peaked at $X in 2020; however, from 2021 to 2022, production remained at a lower figure.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports from Italy

In 2022, shipments abroad of medicaments containing insulin but not antibiotics in measured doses increased by 8.7% to X tons, rising for the third year in a row after two years of decline. Over the period under review, total exports indicated a resilient increase from 2012 to 2022: its volume increased at an average annual rate of +10.1% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, exports increased by +15.4% against 2019 indices. The most prominent rate of growth was recorded in 2013 with an increase of 46% against the previous year. The exports peaked at X tons in 2017; however, from 2018 to 2022, the exports failed to regain momentum.

In value terms, prophylactic medicaments containing insulin exports rose modestly to $X in 2022. In general, exports enjoyed a prominent increase. The growth pace was the most rapid in 2017 when exports increased by 31% against the previous year. Over the period under review, the exports hit record highs at $X in 2020; however, from 2021 to 2022, the exports failed to regain momentum.

Exports by Country

France (X tons) was the main destination for prophylactic medicaments containing insulin exports from Italy, accounting for a 37% share of total exports. Moreover, prophylactic medicaments containing insulin exports to France exceeded the volume sent to the second major destination, China (X tons), threefold. The third position in this ranking was taken by Germany (X tons), with an 11% share.

From 2012 to 2022, the average annual growth rate of volume to France amounted to +17.5%. Exports to the other major destinations recorded the following average annual rates of exports growth: China (+209.0% per year) and Germany (-5.9% per year).

In value terms, France ($X) remains the key foreign market for medicaments containing insulin but not antibiotics in measured doses exports from Italy, comprising 53% of total exports. The second position in the ranking was held by China ($X), with a 19% share of total exports. It was followed by Germany, with an 8% share.

From 2012 to 2022, the average annual growth rate of value to France totaled +11.6%. Exports to the other major destinations recorded the following average annual rates of exports growth: China (+185.5% per year) and Germany (-6.9% per year).

Export Prices by Country

In 2022, the average prophylactic medicaments containing insulin export price amounted to $X per ton, dropping by -4.1% against the previous year. Overall, the export price continues to indicate a mild descent. The growth pace was the most rapid in 2017 when the average export price increased by 27% against the previous year. Over the period under review, the average export prices reached the maximum at $X per ton in 2020; however, from 2021 to 2022, the export prices stood at a somewhat lower figure.

Prices varied noticeably by country of destination: amid the top suppliers, the country with the highest price was China ($X per ton), while the average price for exports to the United States ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to South Korea (+0.8%), while the prices for the other major destinations experienced mixed trend patterns.

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports into Italy

Prophylactic medicaments containing insulin imports into Italy skyrocketed to X tons in 2022, growing by 19% on 2021 figures. Over the period under review, imports, however, recorded a perceptible descent. Over the period under review, imports reached the peak figure at X tons in 2012; however, from 2013 to 2022, imports failed to regain momentum.

In value terms, prophylactic medicaments containing insulin imports surged to $X in 2022. In general, imports, however, recorded a abrupt downturn. Imports peaked at $X in 2012; however, from 2013 to 2022, imports stood at a somewhat lower figure.

Imports by Country

In 2022, France (X tons) constituted the largest supplier of prophylactic medicaments containing insulin to Italy, with a 79% share of total imports. Moreover, prophylactic medicaments containing insulin imports from France exceeded the figures recorded by the second-largest supplier, China (X tons), fourfold. Turkey (X tons) ranked third in terms of total imports with a 2% share.

From 2012 to 2022, the average annual rate of growth in terms of volume from France stood at -2.9%. The remaining supplying countries recorded the following average annual rates of imports growth: China (+8,039.1% per year) and Turkey (0.0% per year).

In value terms, France ($X), China ($X) and Turkey ($X) constituted the largest prophylactic medicaments containing insulin suppliers to Italy, together comprising 96% of total imports.

In terms of the main suppliers, China, with a CAGR of +11,132.2%, saw the highest rates of growth with regard to the value of imports, over the period under review, while purchases for the other leaders experienced mixed trend patterns.

Import Prices by Country

In 2022, the average prophylactic medicaments containing insulin import price amounted to $X per ton, surging by 16% against the previous year. In general, the import price, however, saw a slight descent. The import price peaked at $X per ton in 2012; however, from 2013 to 2022, import prices failed to regain momentum.

Prices varied noticeably by country of origin: amid the top importers, the country with the highest price was China ($X per ton), while the price for Turkey ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by China (+38.0%), while the prices for the other major suppliers experienced a decline.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :